INVESTIGATION OF THE POTENTIAL IMPACT OF BENCHMARK DOSE AND PHARMACOKINETIC MODELING IN NONCANCER RISK ASSESSMENT

Author： Clewell Harvey J.   Gentry P. Robinan   Gearhart Jeffery M.  

Publisher： Taylor & Francis Ltd

ISSN： 1087-2620

Source： Journal of Toxicology and Environmental Health, Vol.52, Iss.6, 1997-12, pp. : 475-515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Physiologically Based Pharmacokinetic Modeling on Benchmark Dose Calculations for TCDD-Induced Biochemical Responses

By Kim A.H.   Kohn M.C.   Portier C.J.   Walker N.J.  

Regulatory Toxicology and Pharmacology, Vol. 36, Iss. 3, 2002-12 ,pp. : 287-296

Academic Press

Access to resources Recommend Favorite

A Unified Approach to Risk Assessment for Cancer and Noncancer Endpoints Based on Benchmark Doses and Uncertainty/Safety Factors1

By Gaylor D.W.   Kodell R.L.   Chen J.J.   Krewski D.  

Regulatory Toxicology and Pharmacology, Vol. 29, Iss. 2, 1999-04 ,pp. : 151-157

Academic Press

Access to resources Recommend Favorite

Uncertainty Factors in Noncancer Risk Assessment

By Dourson M.  

Regulatory Toxicology and Pharmacology, Vol. 24, Iss. 2, 1996-10 ,pp. : 107-107

Academic Press

Access to resources Recommend Favorite

Regulatory Cancer Risk Assessment Based on a Quick Estimate of a Benchmark Dose Derived from the Maximum Tolerated Dose

By Gaylor D.W.   Swirsky Gold L.  

Regulatory Toxicology and Pharmacology, Vol. 28, Iss. 3, 1998-12 ,pp. : 222-225

Academic Press

Access to resources Recommend Favorite

Risk-Benefit Assessment of Opioids in Chronic Noncancer Pain

By Bannwarth B.  

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 283-296

Adis International

Access to resources Recommend Favorite